2-[(1E,3E)-4-Arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones as dienes in Diels-Alder reactions - experimental and computational studies by Albuquerque, Hélio et al.
DOI: 10.1002/ejoc.201601072 Full Paper
Heterocyclic Chemistry
2-[(1E,3E)-4-Arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones as
Dienes in Diels–Alder Reactions – Experimental and
Computational Studies
Hélio M. T. Albuquerque,[a] Clementina M. M. Santos,[a,b] Carlos F. R. A. C. Lima,[a,c]
Luís M. N. B. F. Santos,[c] José A. S. Cavaleiro,[a] and Artur M. S. Silva*[a]
Abstract: The synthesis and reactivity of 2-[(1E,3E)-4-arylbuta-
1,3-dien-1-yl]-4H-chromen-4-ones as dienes in Diels–Alder (DA)
reactions with several electron-poor and electron-rich dieno-
philes under microwave irradiation was studied. The optimized
reaction conditions were achieved with N-methylmaleimide as
the dienophile and Sc(OTf )3 (OTf = triflate) as a Lewis acid un-
der microwave-assisted and solvent-free conditions. The Lewis
acid improved the reaction yields as it prevented the adducts
obtained from undergoing a second DA reaction; thus, the for-
Introduction
Chromones (or 4H-chromen-4-ones) constitute a well-known
class of naturally occurring oxygen-containing heterocycles.
These compounds exhibit important biological properties such
as anticancer,[1] cytotoxic,[2] antioxidant,[1b,3] anti-inflamma-
tory,[4] and antifungal[5] activities. Their reactivities in several
chemical transformations, namely, oxidations, thiations, hydro-
genations, photolysis, condensations, dimerizations, and Diels–
Alder (DA) reactions have been reported widely.[6] Since its dis-
covery in 1928, the DA reaction, including its hetero variant,
has remained an active research field and is the key step in the
synthesis of a large variety of organic compounds.[7]
The use of chromone derivatives as dienes was first reported
in 1954 and involved the DA reaction of 2-styrylchromones with
maleic anhydride,[8] and later with N-arylmaleimides[9] to afford
the corresponding 1,2,3,9a-tetrahydroxanthone adducts. How-
ever, in 1992, Letcher and Yue revised the structure of the ob-
tained adducts to the isomeric 1,2,3,4-tetrahydroxanthones on
the basis of extensive NMR and IR spectroscopy studies.[10]
Years later, Kelkar et al. reported the use of 2-vinylchromones
in [4+2] cycloaddition reactions with electron-rich enamine di-
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mation of a bisadduct was avoided. The α,:γ,δ-diene of the
starting chromones was the most reactive, and the computa-
tional results confirmed the experimental findings. Theoretical
calculations also provided a rationale for the unexpected lack
of reactivity shown by some dienophiles. The adducts prepared
were dehydrogenated with 2,3-dichloro-5,6-dicyano-1,4-benzo-
quinone (DDQ); however, the aza adducts were sensitive to the
highly energetic reaction conditions necessary for the aromati-
zation.
enophiles to provide several xanthone-type compounds.[11] Re-
cently, the reactivity of (E)-2-(4-arylbut-1-en-3-yn-1-yl)chromo-
nes in DA reactions with N-methylmaleimide (NMM) as the di-
enophile was used for the synthesis of xanthone-1,2,3-triazole
dyads.[12] The diene system of (E)-2-(4-arylbut-1-en-3-yn-1-
yl)chromones was unreactive under classical heating condi-
tions; however, the DA reaction under microwave (MW) irradia-
tion afforded the expected 1,2,3,4-tetrahydroxanthone struc-
ture, which was further transformed to the aforementioned
dyads. Meanwhile, our research group also tested the reactivity
of 3-styrylchromones as dienes in [4+2] cycloaddition reactions
with electron-poor dienophiles. Once again, the respective ad-
ducts were obtained in better yields through a MV-assisted pro-
tocol than through classical heating conditions. Owing to the
advantages provided by the use of MV irradiation in DA reac-
tions, experimental and computational studies on the MV-as-
sisted DA reactions of 2-[(1E,3E)-4-arylbuta-1,3-dien-1-yl]-4H-
chromen-4-ones with several electron-poor and electron-rich
dienophiles are disclosed herein. On the basis of the reactivity
of each diene system of the starting chromones, we expected
to synthesize styryl-substituted xanthones (through the DA re-
action of the 3,2:α,-diene) or aryl-substituted flavones
(through the DA reaction of the α,:γ,δ-diene), but the results
indicate that only flavone-type compounds are formed (Fig-
ure 1).
Xanthone and flavone derivatives both have unquestionable
biological benefits, as supported by several reports of their use
as anticancer, antioxidant, and anti-inflammatory agents,
among others.[13] Although the activities of simple xanthone[14]
or flavone[15] scaffolds addresses only one biological target,
there is a general belief that agents that modulate more than
one target could have improved efficiencies compared with
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Figure 1. Two possible sites for DA reactions in 2-[(1E,3E)-4-arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones. R, R′ = electron-withdrawing group (EWG) or electron-
donating group (EDG).
those of single-target drugs for complex multifactorial diseases
such as cancer or Alzheimer's disease.[16] In the present work,
N-methyl- and N-phenylmaleimides were used as dienophiles
to provide dyads bearing the isoindoline-1,3-dione unit, which
is an interesting scaffold that has already been studied in a
multitarget approach for the treatment of cancer[17] and Alz-
heimer's disease.[18] Thus, it is expected that the new hybrid
structures may have greater biological relevance in the multitar-
get-drug research field than the simpler xanthone and flavone
derivatives.
Results and Discussion
DA Reactions of 2-[(1E,3E)-4-Arylbuta-1,3-dien-1-yl]-4H-
chromen-4-ones
2-[(1E,3E)-4-Arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones (3a–3e)
were prepared in good yields (68–80 %) through the base-cata-
lyzed aldol condensation of 2-methyl-4H-chromen-4-one (1)
with the appropriate cinnamaldehyde 2a–2e according to a
previously reported methodology (Scheme 1).[19] 2-Methyl-4H-
chromen-4-one was prepared through a previously reported
three-step Baker–Venkataraman sequence in good overall
yield,[14c] whereas the cinnamaldehydes 2b–2d, which are not
commercially available, were obtained through palladium-cata-
lyzed cross-coupling reactions of aryl iodides with acrolein di-
ethyl acetal.[20]
On the basis of our previous results on the MV-assisted DA
reactions of 2-[(1E)-4-arylbut-1-en-3-yn-1-yl]chromones,[12] we
initially attempted the DA reaction of chromone 3c with in-
Scheme 1. Synthesis of chromones 3a–3e used as dienes in DA reactions.
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creasing amounts of NMM in dry N,N-dimethylformamide (DMF)
for 40 min at 160 °C under multimode MV irradiation (Table 1,
Entries 1–3). Adduct 5c (NMR data in Supporting Information)
was isolated as the major product in 30–31 % yield (Table 1,
Entries 1–3). The DA reaction occurred at the α,:γ,δ-diene, and
the structure of adduct 5c arises from the olefin migration of
the expected DA cycloadduct 4c, which was also isolated
(Table 1, Entry 10). The bisadduct 7c was isolated as a mixture
of four diastereomers (two major diastereomers and traces of
the other two) when a large excess of NMM was employed
(Table 1, Entries 6–9). Its formation should involve a cascade
of four reactions: the DA reaction at the α,:γ,δ-diene gives
intermediate 4c and subsequent olefin migration affords ad-
duct 5c, the diene of which undergoes a new DA reaction to
yield an intermediate structure that provides bisadduct 7c upon
olefin migration (Scheme 2). The formation of bisadduct 7c was
further confirmed by the reaction of the isolated adduct 5c with
NMM under in solvent-free conditions with monomode MV irra-
diation (Table 3). The two major diastereomers found in a
52:48 % mixture were assigned as structures I and II (Scheme 3),
and we were able to isolate the former one in a pure form and
fully characterize it (NMR data in Supporting Information). The
stereochemistry of diastereomer I of bisadduct 7c was assessed
through the observed NOE cross-peaks of (1) H-14c with H-14b
and H-3a; (2) H-4 with H-3a and H-5, which indicate the forma-
tion of the endo product from the first DA reaction; and (3) H-
5b with H-5a and H-8a as well as the absence of close proximity
between H-5a with H-14b, which suggests that the second DA
reaction also afforded an endo adduct. However, the second
addition can occur at the same face as the first one to yield
the endo/endo(cis) adduct or at the opposite face to afford the
endo/endo(trans) adduct (Scheme 3). Then, each one of these
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diastereomers undergoes olefin migration to provide two dia-
stereomers. In the NOESY spectrum of a mixture enriched in
diastereomer II of bisadduct 7c, one can deduce the close prox-
imity of H-5a with H-5b and H-14b as well as H-5b with H-8a,
which confirms the endo/endo(cis) diastereomer (Scheme 3). In
the spectrum of the crude reaction mixture, we observed the
typical signals of the diastereomers I and II as well as other
small ones corresponding to the H-8a, OMe, and N-Me signals
of another two compounds, which were assigned to diastereo-
mers III and IV (trace amounts). The variation of the tempera-
Table 1. Optimization of the DA reaction of chromone 3c with NMM under multimode MW irradiation. The reactions were performed in dry DMF (10 μL).
Entry NMM T Time 5c 7c 3c Entry NMM T Time 5c 7c 3c
[equiv.] [°C] [min] Yield [%][a] Yield [%][b] Recovered [%][a] [equiv.] [°C] [min] Yield [%][a] Yield [%][b] Recovered [%][a]
1 1 160 40 31 – 10 6 10 160 10 48 28 –
2 3 160 40 30 – – 7 15 160 20 21 31 –
3 5 160 40 30 7 – 8 10 160 40 21 21 –
4 5 160 20 35 25 – 9 10 100 20 25 17 Traces
5[c] 5 160 10 22 Traces Traces 10[d] 10 130 10 30 Traces Traces
[a] Isolated yields. [b] Isolated yield of a mixture of diastereomers. [c] Derivative 6c isolated in 6 % yield. [d] Derivative 4c isolated in 8 % yield.
Scheme 2. Tandem DA/olefin migration processes to form bisadduct 7c.
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ture, reaction time, or dienophile amount did not improve the
yields of adduct 5c or bisadduct 7c (Table 1, Entries 4–10). Inter-
estingly, if the reaction was performed for 10 min, adduct 6c
(NMR data in Supporting Information) was isolated in 6 % yield
(Table 1, Entry 5). In this case, the DA reaction occurred at the
3,2:α,-diene to give a styryl-substituted tetrahydroxanthene
structure. By performing the reaction at 130 °C, it was possible
to isolate derivative 4c in 8 % yield (Table 1, Entry 10). This
confirms that the more stable adduct 5c results from the olefin
migration of the expected DA cycloadduct 4c (NMR data in
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Scheme 3. Stereochemistry (NOESY) of the olefin migration of 7c endo/endo(trans) and endo/endo(cis) products.
Supporting Information). Our aforementioned preliminary ex-
perimental results strongly suggest that the α,:γ,δ-diene sys-
tem is the most reactive or at least affords the more thermody-
namically stable DA product. To obtain more insights into this
DA reaction, we evaluated its thermodynamic feasibility by
computational methods at the M06-2X/6-31+G(d,p) level of
theory (detailed results are presented in Table S1). We started
with the conformational analysis of the reactants 3a, 3c, 3d,
and 3e, as only the cis double bonds are reactive towards the
DA reaction.
The results indicate that the all-trans reactant is the major
species with a molar fraction of around 0.89 at T = 160 °C (the
temperature at which most reactions were performed). The spe-
cies with all cis double bonds has a molar fraction of less than
0.01 and can in principle be ignored. The two reactive conform-
ers cis-3,2:α,-diene (which yields 6 upon DA reaction) and cis-
α,:γ,δ-diene (which yields 4) are present in small amounts of
ca. 0.08 and 0.02, respectively. However, as the conversion be-
tween these isomers is rather fast at high temperatures, these
quantities should suffice for the respective DA reactions to pro-
ceed smoothly.[21] The influence of the substituent R group (Fig-
ure 1) in the conformational distribution was found to be negli-
gible. The calculated energy levels of the highest occupied mo-
lecular orbital and the lowest unoccupied molecular orbital
(HOMO/LUMO) confirm the kinetic viability of the direct DA re-
action through comparison with the calculated HOMO and
LUMO of the NMM dienophile (Table S4, Supporting Informa-
tion) and also vary very little with the substituent R.
These results suggest that the influence of the R group on
the intrinsic thermodynamic and kinetic DA reactivity of 3 is of
minor importance, as is consistent with the rather large dis-
tance of the substituent from the reactive diene centers. Hence,
to speed up the calculations, only 3a (R = H) was considered
for the subsequent computational studies. We also evaluated
each possible reaction of 3a with NMM separately to yield the
four possible products (4a, 5a, 6a, and 7a) presented in Table 1.
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As 4a, 5a, and 6a are isomers, the direct comparison between
their energies gives information about which reaction pathway
is thermodynamically preferred (Table S2, Supporting Informa-
tion). The optimized structures of 4a, 5a, 6a, and 7a are pre-
sented in Table S5 (Supporting Information); various possible
stable conformations were found for these compounds, but
only the minimum energy configurations were considered. The
energetic analysis indicates that the stabilities of 5a and 6a are
very similar, ΔH298K(5a→6a) ≈ 0 kJ mol–1 (H298K is the calculated
enthalpy at T = 298.15 K). However, the energy difference be-
tween their precursors, 4a and 6ai, respectively, which are
formed through the initial DA reaction and before the olefin
migration, is much more substantial, ΔH298K(4a→6ai) ≈
29 kJ mol–1. The ΔH298K values for the olefin migrations were
calculated as –27 kJ mol–1 for 4a→5a and –57 kJ mol–1 for
6ai→6a. The computational results also indicate that the DA
reactions with NMM (3→4, 3→6, 5→7) are significantly favored
energetically, and the calculated ΔrH298K values are in the order
of –120 to –150 kJ mol–1. To better visualize these results, the
calculated relative enthalpy (T = 298.15 K) versus reaction coor-
dinate diagram is shown in Figure 2 for the DA reaction of
3a with NMM (to yield the two intermediates 4a and 6ai) and
subsequent olefin migration (to form 5a and 6a, respectively).
These results support the experimental findings by indicat-
ing that (1) 6 should be a minor product of the DA reaction, (2)
the preferred pathway for product 7 should be a second DA
reaction of 5, and (3) the olefin migration of the DA adducts
should be thermodynamically spontaneous.
To improve the yields of adducts 5, the reaction was per-
formed under solvent-free conditions with monomode MV irra-
diation. Thus, the DA reaction of chromone 3c with NMM was
performed with the variation of the amount of dienophile and
the reaction time (Table 2, Entries 1–5). The best yield for ad-
duct 5c (47 %) was obtained in 10 min with 2 equiv. of NMM,
and 5 % of the starting chromone 3c was recovered (Table 2,
Entry 3). The reactions at 130 and 100 °C with 2 equiv. of NMM
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Figure 2. Enthalpy (at T = 298.15 K) versus reaction coordinate diagram for
the DA reaction of 3a with NMM, calculated at the M06-2X/6-31+G(d,p) level
of theory.
for 15 min (Table 2, Entries 6 and 7) afforded less byproduct,
and the yield of adduct 5c was higher at 130 °C, at which 37 %
of the starting chromone 3c was recovered. Owing to the mod-
erate yields of adduct 5c, the influence of the Lewis acid was
assessed. If a stoichiometric amount of AlCl3 was employed at
different temperatures, adduct 5c was obtained in low yields
(27–29 %), and 45–57 % of the starting chromone 3c was recov-
ered (Table 2, Entries 8 and 9). If the Lewis acid was changed
to Sc(OTf )3 (OTf = triflate) and the amount of dienophile was
Table 2. The optimization of the DA reaction of chromones 3a–3e with NMM under solvent-free conditions with monomode MW irradiation.
Entry Derivative NMM T Time Lewis acid 5 3
[equiv.] [°C] [min] Yield [%][a] Recovered [%][a]
1 3c 1 165 15 – 37 33
2 3c 2 165 15 – 44 –
3 3c 2 165 10 – 47 5
4 3c 2 165 5 – 45 26
5[b] 3c 5 165 15 – 25 –
6 3c 2 130 15 – 40 37
7 3c 2 100 15 – 20 66
8[c] 3c 2 165 10 AlCl3 29 45
9[c] 3c 2 130 15 AlCl3 27 57
10[c] 3c 2 165 10 Sc(OTf)3 62 21
11[c] 3c 3 165 10 Sc(OTf)3 67 5
12[c] 3c 4 165 10 Sc(OTf)3 67 8
13[d] 3c 3 165 10 Sc(OTf)3 37 –
14[c] 3c 2 165 15 Sc(OTf)3 59 26
15[c] 3c 2 130 15 Sc(OTf)3 47 17
16[c] 3a 3 165 10 Sc(OTf)3 77 –
17[c] 3b 3 165 10 Sc(OTf)3 55 14
18[c] 3d 3 165 10 Sc(OTf)3 71 –
19[c] 3e 3 165 10 Sc(OTf)3 52 25
[a] Isolated yield. [b] 25 % of bisadduct 7c was isolated. [c] 100 mol-% of Lewis acid. [d] 30 mol-% of Lewis acid.
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varied, the yield of adduct 5c increased to 62–67 %, and the
best yield was achieved with 3 or 4 equiv. of NMM (Table 2,
Entries 10–12). A single reaction was attempted with 30 mol-%
of Sc(OTf )3 for 10 min at 165 °C (Table 2, Entry 13), but, unfortu-
nately, the yield of adduct 5c decreased to 37 %; this result
implies that the effect of Sc(OTf )3 is stoichiometric rather than
catalytic. In our particular case, the Lewis acid can complex with
the carbonyl groups of NMM or with the carbonyl group of
chromone 3c. The chelation with NMM makes this dienophile
more electron-poor and, as a consequence, the DA reaction is
favored with an electron-rich diene. Furthermore, the chelation
of the Lewis acid with the carbonyl group of chromone 3c
makes the 3,2:α,-diene more electron-poor, and the DA reac-
tion at this site is disfavored (Figure 3A). The chelation with the
carbonyl group of adduct 5c also makes the newly formed di-
ene more electron-poor; once again, the DA reaction is disfav-
ored and, consequently, the yield of bisadduct 7c decreases
(Figure 3B).
To reinforce this idea, DA reactions of adduct 5c with an
excess of NMM in the presence or absence of Sc(OTf )3 were
performed (Table 3, Entries 1–3). Both DA reactions performed
in the absence of Sc(OTf )3 afforded bisadduct 7c as a mixture of
diastereomers in 48 and 60 % yield with 20–37 % of the starting
adduct 5c recovered (Table 3, Entries 1 and 2). For the reaction
in the presence of a stoichiometric amount of Sc(OTf )3, bisad-
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Figure 3. Effect of Lewis acid on the DA reaction: (A) chelation with chromone
3c and NMM, (B) chelation with adduct 5c and N-methyl-
maleimide.
duct 7c was obtained as a mixture of diastereomers in only
15 % yield, and 75 % of 5c was recovered (Table 3, Entry 3).
These results confirm our suspicions that the Lewis acid chela-
tion makes the 3,2:α,-diene more electron-poor and directs
the DA reaction towards 5c.
Table 3. DA reaction of 5c with NMM in the presence or absence of Sc(OTf)3.
Reactions performed with 6 equiv. of NMM.
Entry Time Lewis acid 7c 5c
[min] Yield [%][a] Recovered [%][b]
1 20 – 48 37
2 30 – 60 20
3[c] 20 Sc(OTf)3 15 75
[a] Isolated yield of a mixture of diastereomers. [b] Isolated yield. [c] 100 mol-
% of Lewis acid.
The best reaction conditions for adduct 5c were achieved
with 3 equiv. of NMM in the presence of 1 equiv. of Sc(OTf )3
for 10 min at 165 °C (Table 2, Entry 11). The same conditions
were applied to chromones 3a, 3b, 3d, and 3e (Table 2, En-
tries 16–19), and the corresponding adducts 5a, 5b, 5d, and 5e
were obtained in moderate-to-good yields (52–77 %). To con-
firm our previous suggestion for the formation of the endo ad-
duct 5, a NOESY experiment was performed on adduct 5e to
address the stereochemistry of the reaction. The NOE cross-
peaks showed the close proximity of H-3a with H-4 and H-7a;
therefore, the adducts 5 are endo products (Figure 4).
The effect of Lewis acid chelation was further evaluated by
computational chemistry at the M06-2X/6-31+G(d,p) level of
theory (the detailed results are presented in the Supporting
Information). The results indicate that Sc(OTf )3 will bind prefer-
entially to the C=O group of the chromone ring, and chelation
with other groups or atoms of the diene or the dienophile is of
minor importance. Chelation with a Lewis acid seems not to
alter significantly the shapes of the HOMOs and LUMOs of 3a
and 5a. However, the computational results suggest that chela-
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Figure 4. Most important NOE cross-peaks of adduct 5e.
tion reduces the overall reactivity of the dienes towards the DA
reaction because it (1) increases the HOMO/LUMO gap between
the diene and dienophile (by decreasing the HOMO energy of
the diene) and (2) decreases the double-bond character of the
reactive chromone double bond and, thus, decreases the react-
ivity of the 3,2:α,-diene. Hence, on the basis of the experimen-
tal and computational findings, the most probable cause for
the increased yield of product 5 in the presence of Sc(OTf )3 is
that chelation reduces the reactivity of 5 towards the second
DA reaction, which consumes it to afford bisadduct 7.
With these results in hand, we turned our attention to the
scope of dienophiles in DA reactions with chromone 3c, as de-
picted in Table 4. N-Phenylmaleimide afforded adduct 8 in 66 %
yield (Table 4, Entry 1). The reactivities of dimethyl and diethyl
acetylenedicarboxylate with chromone 3c were also tested, and
the expected aromatic products 9a and 9b (NMR data in Sup-
porting Information) were obtained in 30–45 % yield (Table 4,
Entries 2–4).
The dienophile scope was further extended to diethyl and
diisopropyl azodicarboxylate (DEAD and DIAD, respectively;
Table 4, Entries 5 and 6) to afford the expected adducts 10a
and 10b in 22 and 57 % yield, respectively. In the reaction with
DEAD, derivative 11 was isolated in 22 % yield as the product
of an Alder-ene reaction of adduct 10a. The formation of this
Alder-ene product 11 (NMR data in Supporting Information)
can be explained on the basis of a tandem DA/Alder-ene proc-
ess (Scheme 4). To avoid the formation of the Alder-ene product
11, the reaction was attempted at 80 and 100 °C; however, no
reaction products were observed. By performing the reaction
at 130 °C, cycloadduct 10a was isolated in trace amounts to-
gether with unreacted chromone 3c and derivative 11 in 30 %
yield. 4-Phenyl-1,2,4-triazoline-3,5-dione (PTAD) was expected
to show similar or even improved reactivity compared with
those of maleimides or azodicarboxylates. Unfortunately, no DA
products were observed when the reaction was performed at
different temperatures and in the presence or absence of DMF
as solvent (Table 4, Entries 7–9). The reason for this may be that
the high temperatures employed in DA reactions probably lead
to the dimerization of PTAD,[22] and this reaction competes with
the DA reaction. Electron-poor dienophiles such as diethyl
fumarate and maleate were extremely reluctant towards the DA
reaction with chromone 3c. Even at higher temperatures and
longer reaction times, no DA reaction was observed. Instead,
more degradation products and less recovered chromone were
detected (Table 4, Entries 10–13). Reactions involving the elec-
tron-rich dienophile 3,4-dihydro-2H-pyran (Table 4, Entries 14
and 15) were attempted at different temperatures, but no DA
reaction occurred.
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Table 4. Dienophile scope in the DA reactions of chromone 3c under monomode MW irradiation; the reactions were performed under solvent-free or neat
conditions.
[a] Isolated yield. [b] Addition of 100 mol-% of Sc(OTf)3. [c] DMF (0.1 mL) as solvent. [d] Unidentified byproducts. [e] The reaction with DEAD afforded the
expected DA cycloadduct and the other product from the tandem DA/Alder-ene process.
In general, the relative reactivity of the dienophiles is indi-
cated accurately by the calculated HOMO(diene)/LUMO(dieno-
phile) energy differences, and there is some tendency for higher
yields to be observed for lower HOMO/LUMO energy gaps. For
instance, the highest HOMO/LUMO gap was observed for the
dienophile in Table 4, Entries 14 and 15, the low reactivity of
which may explain why no DA reaction occurred. The HOMO/
LUMO energies were calculated at the M06-2X/6-31+G(d,p) and
MP2/6-31+G(d,p) levels of theory. The detailed results are pre-
sented in Table S4 (Supporting Information), and both methods
predict similar tendencies in the HOMO/LUMO energies. How-
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ever, there are some cases that deviate from this analysis. In
Table 4, Entries 7–9 and 12–13, although the calculated HOMO/
LUMO gaps are slightly higher than those for the most reactive
dienophiles, the absence of DA reaction may mostly be due to
the extensive decomposition of the dienophile in the reaction
medium. For Table 4, Entries 10 and 11, the failure of the DA
reaction is harder to explain; the HOMO/LUMO gap is compara-
ble to those of the most reactive dienophiles, no unidentified
byproducts were detected, and most of the unreacted reagent
was recovered. Therefore, we turned our attention to the corre-
sponding DA product analogous to 5.
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Scheme 4. Tandem DA/Alder-ene process to form 11.
The optimized geometry of this product (presented in
Table S5, Supporting Information) evidences the existence of
significant steric repulsion between the ester groups and the
chromone and phenyl rings. This increases the calculated
ΔrH298K for the DA reaction between 3a and diethyl fumarate
to yield the product analogous to 5a by ca. 10 and 40 kJ mol–1
relative to the reaction 3a + NMM → 5a and the analogous
reactions involving the similar dienophiles used in Table 4, En-
tries 5 and 6, respectively (Table S3, Supporting Information).
In these last cases, the geometries of the N atoms in the DA
products avoids significant steric repulsions, and the reactions
are more favored. This computational analysis suggests that the
DA reaction between 3 and the dienophiles in Table 4, En-
tries 10–13, to yield the products analogous to 4 and 5 is ther-
modynamically or kinetically less favored owing to significant
intramolecular steric repulsion.
Table 5. Aromatization of adducts 5a–5e.
Entry Adduct DDQ Heating method Solvent T [°C] Time 12 13c
[equiv.] Yield [%][a] Yield [%][a]
1 5c 3 oil bath toluene 100 4 h 34 60
2 5c 5 oil bath 1,4-dioxane 100 4 h – 52
3 5c 3 oil bath 1,2,4-TCB 190 24 h 38 15
4 5c 4 MW[b] 1,2,4-TCB 165 25 min 90 –
5 5a 4 MW[b] 1,2,4-TCB 165 25 min 85 –
6 5b 4 MW[b] 1,2,4-TCB 165 25 min 75 –
7 5d 4 MW[b] 1,2,4-TCB 165 25 min 80 –
8 5e 4 MW[b] 1,2,4-TCB 165 25 min 70 –
[a] Isolated yield. [b] Monomode MW irradiation.
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Aromatization of DA Adducts
Once adducts 5a–5e were obtained, we thought it would be
interesting to further aromatize them to flavone derivatives.
Several methodologies using 2,3-dichloro-5,6-dicyanobenzo-
quinone (DDQ) have been reported;[23] nevertheless, our initial
choice was a successful method that we employed previously
for similar oxidations.[12] Therefore, adduct 5c was heated in
toluene at 100 °C with 3 equiv. of DDQ (Table 5, Entry 1). After
4 h, the starting adduct 5c was consumed, and the oxidized
product 12c was obtained in 34 % yield, together with the
semioxidized product 13c (NMR data in Supporting Informa-
tion) in 60 % yield (Table 5, Entry 1). With a more polar solvent,
1,4-dioxane, and an increased amount of DDQ (Table 5, Entry 2),
only the semioxidized derivative 13c was obtained in 52 %
yield. With 1,2,4-trichlorobenzene (1,2,4-TCB) as the solvent
(Table 5, Entry 3), the semioxidized derivative 13c was isolated
in 15 %; however the oxidized derivative 12c was obtained in
only 38 % yield. The low yields of derivative 12c can be ex-
plained on the basis of the stability given by the presence of a
conjugate diene in the semioxidized derivative 13c. Further-
more, the relatively long reaction times may contribute to the
degradation of either the starting adduct or the oxidized prod-
ucts. MV-assisted reaction conditions were employed for the
oxidation of adduct 5c in 1,2,4-TCB at 165 °C for 25 min (Table 5,
Entry 4); the desired oxidized derivative 12c was obtained in
90 % yield, and no semioxidized product 13c was detected.
These reaction conditions were also applied to adducts 5a, 5b,
5d, and 5e to afford the oxidized products 12a, 12b, 12d, and
12e (NMR data in Supporting Information) in high yields
(Table 5, Entries 5–8). At this stage, derivatives 12a–12e were
obtained in two steps; the intermediate DA adducts 5a–5e
were isolated in the first step and further oxidized with DDQ.
To address if the oxidation of adducts 5 without purification
was advantageous, chromone 3c was reacted with NMM in the
presence of Sc(OTf )3, and the formed adduct was oxidized with
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DDQ in 1,2,4-TCB at 165 °C for 25 min in a one-pot process. The
oxidized product 12c was obtained in 16 % yield along with
adduct 5c in 28 % yield. The low yield of 12c can be explained
by the chelation of the Lewis acid with the carbonyl group of
adduct 5c; the chelation makes the cyclohexene ring electron-
poor by conjugation, and the hydride sabstraction by DDQ is
disfavored. The same experiment was performed under the
same reaction conditions but in absence of the Lewis acid. Un-
fortunately, the reaction afforded the oxidized product 12c only
in 20 % yield, and no adduct 5c was isolated. In the absence of
Lewis acid, the DA reaction affords more byproducts, including
the bisadduct 7c, and this may be the reason that the yield of
the oxidized product 12c is not improved in the absence of
Sc(OTf )3. To sum up, the one-pot DA/oxidation processes was
an inefficient and disadvantageous methodology compared to
the two-step procedure.
Adduct 8 was also oxidized under the best reaction condi-
tions for adducts 5a–5e to afford derivative 14 in 86 % yield
(Scheme 5).
Scheme 5. Aromatization of adduct 8.
The oxidations of cycloadducts 10a and 10b were not
straightforward, because C–N bonds break readily upon oxid-
ation. Therefore, the initial oxidation conditions employed to
cycloadduct 10a were less harsh, and DDQ was used in 1,4-
dioxane at 100 °C for 24 h. Unfortunately, no oxidized product
was detected, and 72 % of the starting cycloadduct 10a was
recovered. Therefore, highly energetic conditions were em-
ployed with DDQ in 1,2,4-TCB at 165 °C under MV irradiation
for 25 min. Several unidentified byproducts were observed, and
no oxidized product was detected.
Despite the unsuccessful attempts to oxidize cycloadduct
10a, the aromatization of cycloadduct 10b was also attempted
under MV irradiation (Scheme 6). The oxidation process oc-
curred but was inefficient, as the oxidized product 15b was
isolated in only 17 % yield. In the 1H NMR spectrum of deriva-
tive 15b, two broad singlets at δ = 6.07 and 7.88 ppm, assigned
to 1-NH and 4-NH, respectively, indicated that the N–N single
bond of the cycloadduct 10b was broken during the oxidation
reaction.
Scheme 6. Aromatization of cycloadduct 10b.
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Conclusions
The α,:γ,δ-diene system of chromones 3 were the most react-
ive in DA reactions with NMM as the dienophile to afford com-
pounds 5, which form through a DA reaction followed by an
olefin migration. These results were confirmed by computa-
tional studies, which indicated that derivative 6 (DA reaction at
the 3,2:α,-diene, followed by an olefin migration) should be a
minor product of DA reaction and that adducts 5 are thermody-
namically more stable. However, for the DA reaction in DMF
with an excess of NMM, the yields of adducts 5 were lower,
and several byproducts were detected. The most relevant one
resulted from a tandem DA/olefin migration/DA/olefin migra-
tion process to afford bisadduct 7 as a mixture of diastereo-
mers. The formation of this byproduct was prevented by using
Sc(OTf )3 under solvent-free conditions, and, consequently, ad-
ducts 5 were obtained in higher yields. An investigation of the
scope of dienophiles allowed us to conclude that electron-poor
dienophiles are most reactive and that no DA reaction occurred
for electron-rich dienophiles. The adducts obtained with
maleimides were aromatized in high yields with DDQ under MV
irradiation. However, the aromatization was not straightforward
for aza adducts owing to the sensitive N–N single bonds, which
were broken readily. The combination of the experimental and
computational findings also indicates that the main features
of the DA reactions studied are described accurately by the
thermodynamic stabilities of the reaction products and inter-
mediates and the HOMO/LUMO evaluation of the dienes and
dienophiles within the frontier molecular orbitals (FMO) ap-
proach.
Experimental Section
General: The melting points were measured with a Büchi B-540
melting-point apparatus. The NMR spectra were recorded with a
Bruker Avance 300 spectrometer (300.13 MHz for 1H and 75.47 MHz
for 13C) or Bruker Avance 500 spectrometer (500.13 MHz for 1H and
125.77 MHz for 13C). Chemical shifts (δ) are reported in ppm, and
coupling constants (J) are in Hz; the internal standard was tetra-
methylsilane (TMS). Unequivocal 13C NMR assignments were made
with the aid of 2D gradient heteronuclear single quantum coher-
ence (gHSQC) and gradient HMBC (gHMBC; delays for one-bond
long-range C–H couplings were optimized for 145 and 7 Hz, respec-
tively) experiments. Positive-ion ESI mass spectra were acquired
with a QTOF 2 instrument. The sample (1 μL) in chloroform solution
(ca. 10–5 M) was diluted in 0.1 % trifluoroacetic acid/methanol solu-
tion (200 μL). Nitrogen was used as nebulizer gas, and argon was
used as the collision gas. The needle voltage was set to 3000 V, the
ion source was set to 80 °C, and the desolvation temperature was
150 °C. The cone voltage was 35 V. Other low- and high-resolution
mass spectra (EI, 70 eV) were measured with VG Autospec Q and
M spectrometers. Elemental analyses were obtained with a LECO
932 CHNS analyzer. Preparative TLC was performed with Merck silica
gel (60 DGF254). Column chromatography was performed with
Merck silica gel (60, 70–230 mesh). All chemicals and solvents used
were obtained from commercial sources and used as received or
dried by standard procedures.
General Procedure for the Synthesis of 2-[(1E,3E)-4-Arylbuta-
1,3-dien-1-yl]-4H-chromen-4-ones 3a–3e: Sodium (0.11 g,
4.8 mmol) was added gradually to dry ethanol (5 mL), and the mix-
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ture was stirred until it reached room temperature. 2-Methyl-
chromone (1, 0.2 g, 1.2 mmol) and the appropriate cinnamaldehyde
2a–2e (1.5 mmol) were added, and the reaction mixture was al-
lowed to stand at room temperature until the 2-methylchromone
disappeared completely. The solution was then poured into ice and
water, and the pH was adjusted to 4 with dilute HCl. The solid was
removed by filtration, dissolved in dichloromethane, and purified
by silica gel column chromatography with dichloromethane as the
eluent. The solvent was evaporated, and the residue was recrystal-
lized from ethanol to give the 2-[(1E,3E)-4-arylbuta-1,3-dien-1-yl]-
4H-chromen-4-ones 3a–3e.
2-[(1E,3E)-4-Phenylbuta-1,3-dien-1-yl]-4H-chromen-4-one (3a):
Yield 263 mg (80 %), orange solid, m.p. 144–146 °C (from EtOH). 1H
NMR (300 MHz, CDCl3): δ = 6.27 (s, 1 H, 3-H), 6.38 (d, J = 15.3 Hz, 1
H, H-α), 6.91–7.03 (m, 2 H, H-γ, H-δ), 7.31–7.45 (m, 6-H, H-, 3′,4′,5′-
H), 7.48–7.51 (m, 1 H, 8-H), 7.52 (d, J = 8.5 Hz, 2 H, 2′,6′-H), 7.68
(ddd, J = 8.6, 7.1, 1.7 Hz, 1 H, 7-H), 8.19 (dd, J = 7.9, 1.7 Hz, 1 H, 5-
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 110.3 (C-3), 117.8 (C-8), 123.6
(C-α), 124.1 (C-4a), 125.0 (C-6), 125.7 (C-5), 127.1 (C-2′,6′, C-γ), 128.9
(C-3′,5′), 129.0 (C-4′), 133.7 (C-7), 136.3 (C-1′), 137.4 (C-), 139.1 (C-
δ), 156.0 (C-8a), 161.8 (C-2), 178.4 (C-4) ppm. EI-MS: m/z (%) = 274
(35) [M]+·, 273 (100) [M – H]+, 257 (26), 221 (24), 197 (48). EI-HRMS:
calcd. for C19H14O2 [M]+ 274.0994; found 274.0999.
2-[(1E,3E)-4-(4-Chlorophenyl)buta-1,3-dien-1-yl]-4H-chromen-4-
one (3b): Yield 259 mg (70 %), yellow solid, m.p. 180–182 °C (from
EtOH). 1H NMR (300 MHz, CDCl3): δ = 6.27 (s, 1 H, 3-H), 6.39 (d, J =
15.2 Hz, 1 H, H-α), 6.86–6.99 (m, 2 H, H-γ, H-δ), 7.34 (d, J = 8.6 Hz,
2 H, 3′,5′-H), 7.34–7.48 (m, 2 H, H-, 6-H), 7.42 (d, J = 8.6 Hz, 2 H,
2′,6′-H), 7.50 (dd, J = 8.5, 1.1 Hz, 1 H, 8-H), 7.68 (ddd, J = 8.5, 7.1,
1.7 Hz, 1 H, 7-H), 8.19 (dd, J = 7.9, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 110.5 (C-3), 117.8 (C-8), 124.1 (C-4a), 124.2
(C-α), 125.0 (C-6), 125.7 (C-5), 127.6 (C-γ), 128.2 (C-2′,6′), 129.1
(C-3′,5′), 133.8 (C-7), 134.6, 134.7 (C-1′ and C-4′), 137.0 (C-), 137.6
(C-δ), 156.0 (C-8a), 161.6 (C-2), 178.4 (C-4) ppm. EI-MS: m/z (%) =
310 (37Cl, 9) [M + H]+, 309 (37Cl, 23) [M]+·, 308 (35Cl, 28) [M + H]+,
307 (35Cl, 100) [M]+·, 291 (20), 197 (35), 152 (24). EI-HRMS: calcd. for
C19H1235ClO2 [M – H]+ 307.0526; found 307.0567.
2-[(1E,3E)-4-(4-Methoxyphenyl)buta-1,3-dien-1-yl]-4H-chrom-
en-4-one (3c): Yield 292 mg (80 %), yellow solid, m.p. 137–139 °C
(from EtOH). 1H NMR (300 MHz, CDCl3): δ = 3.84 (s, 3 H, OCH3), 6.24
(s, 1 H, 3-H), 6.32 (d, J = 15.3 Hz, 1 H, H-α), 6.84–6.87 (m, 1 H, H-δ),
6.90 (d, J = 8.8 Hz, 2 H, 3′,5′-H), 6.90–6.96 (m, 1 H, H-γ), 7.38 (ddd,
J = 8.2, 7.1, 0.9 Hz, 1 H, 6-H), 7.41–7.44 (m, 1 H, H-), 7.43 (d, J =
8.8 Hz, 2 H, 2′,6′-H), 7.49 (d, J = 8.1 Hz, 1 H, 8-H), 7.67 (ddd, J = 8.1,
7.1, 1.7 Hz, 1 H, 7-H), 8.18 (dd, J = 8.2, 1.7 Hz, 1 H, 5-H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 55.3 (OCH3), 109.9 (C-3), 114.3 (C-3′,5′),
117.7 (C-8), 122.3 (C-α), 124.1 (C-4a), 124.8 (C-6), 125.0 (C-γ), 125.5
(C-5), 128.5 (C-2′,6′), 128.6 (C-1′), 133.6 (C-7), 137.8 (C-), 138.9 (C-
δ), 140.4 (C-8a), 160.3 (C-4′), 162.0 (C-2), 178.4 (C-4) ppm. EI-MS: m/z
(%) = 304 (68) [M]+·, 303 (100) [M – H]+, 287 (27), 197 (23). EI-HRMS:
calcd. for C20H16O3 [M]+ 304.1099; found 304.1098.
2-[(1E,3E)-4-(4-Methylphenyl)buta-1,3-dien-1-yl]-4H-chromen-
4-one (3d): Yield 266 mg (77 %), orange solid, m.p. 144–147 °C
(from EtOH). 1H NMR (300 MHz, CDCl3): δ = 2.37 (s, 3 H, CH3), 6.25
(s, 1 H, 3-H), 6.35 (d, J = 15.2 Hz, 1 H, H-α), 6.88–6.99 (m, 2 H, H-γ,
H-δ), 7.19 (d, J = 8.0 Hz, 2 H, 3′,5′-H), 7.36–7.46 (m, 2 H, H-, 6-H),
7.39 (d, J = 8.0 Hz, 2 H, 2′,6′-H), 7.49 (dd, J = 8.5, 1.0 Hz, 1 H, 8-H),
7.67 (ddd, J = 8.5, 7.1, 1.6 Hz, 1 H, 7-H), 8.19 (dd, J = 8.0, 1.6 Hz, 1
H, 5-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 110.1 (C-3),
117.8 (C-8), 123.0 (C-α), 124.1 (C-4a), 124.9 (C-6), 125.7 (C-5), 126.2
(C-γ), 127.1 (C-2′,6′), 129.6 (C-3′,5′), 133.5 (C-1′), 133.6 (C-7), 137.7
(C-), 139.2 (C-δ, C-4′), 156.0 (C-8a), 161.9 (C-2), 178.4 (C-4) ppm. EI-
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MS: m/z (%) = 288 (40) [M]+·, 287 (100) [M – H]+, 271 (22), 197 (33).
EI-HRMS: calcd. for C20H16O2 [M]+ 288.1150; found 288.1149.
2-[(1E,3E)-4-(4-Nitrophenyl)buta-1,3-dien-1-yl]-4H-chromen-4-
one (3e): Yield 260 mg (68 %), yellow solid, m.p. 198–200 °C (from
EtOH). 1H NMR (300 MHz, CDCl3): δ = 6.32 (s, 1 H, 3-H), 6.51 (d, J =
15.2 Hz, 1 H, H-α), 6.95–7.15 (m, 2 H, H-γ, H-δ), 7.38–7.48 (m, 2 H,
H-, 6-H), 7.51 (dd, J = 8.7, 1.0 Hz, 1 H, 8-H), 7.62 (d, J = 8.8 Hz, 2
H, 2′,6′-H), 7.70 (ddd, J = 8.7, 7.1, 1.7 Hz, 1 H, 7-H), 8.20 (dd, J = 7.9,
1.7 Hz, 1 H, 5-H), 8.24 (d, J = 8.8 Hz, 2 H, 3′,5′-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 111.3 (C-3), 117.8 (C-8), 124.1 (C-4a), 124.3 (C-
3′5′), 125.2 (C-6), 125.8 (C-5), 126.5 (C-α), 127.4 (C-2′,6′), 131.2 (C-γ),
133.9 (C-7), 135.89, 135.94 (C- and C-δ), 142.5 (C-1′), 147.4 (C-4′),
156.0 (C-8a), 161.0 (C-2), 178.5 (C-4) ppm. EI-MS: m/z (%) = 319 (57)
[M + H]+, 318 (100) [M]+·, 289 (50), 288 (35), 272 (33), 197 (73),
152 (27). EI-HRMS: calcd. for C19H12NO4 [M – H]+ 318.0766; found
318.0765.
4-(4-Methoxyphenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (4c): This com-
pound was isolated from the reaction of 3c (37 mg, 0.121 mmol)
with NMM (134 mg, 1.21 mmol) in dry DMF (10 μL) at 130 °C for
10 min in a multimode MV apparatus, and the residue was purified
by preparative TLC with ethyl acetate/hexane (1:1) as the eluent.
(4 mg, 8 %). 1H NMR (300 MHz, CDCl3): δ = 2.57 (s, 3 H, NCH3), 3.40–
3.49 (m, 2 H, 3a-H, 7a-H), 3.78 (s, 3 H, OCH3), 3.95–3.99 (m, 1 H, 4-
H), 4.25–4.27 (m, 1 H, 7-H), 6.14 (ddd, J = 9.9, 4.4, 1.9 Hz, 1 H, 6-H),
6.33 (ddd, J = 9.9, 5.0, 2.0 Hz, 1 H, 5-H), 6.40 (s, 1 H, 3′-H), 6.83 (d,
J = 8.7 Hz, 2 H, 3′′,5′′-H), 7.00 (d, J = 8.7 Hz, 2 H, 2′′,6′′-H), 7.43 (ddd,
J = 8.0, 7.1, 1.1 Hz, 1 H, 6′-H), 7.48 (dd, J = 8.3, 1.1 Hz, 1 H, 8′-H),
7.70 (ddd, J = 8.3, 7.1, 1.7 Hz, 1 H, 7′-H), 8.21 (dd, J = 8.0, 1.7 Hz, 1
H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.4 (NCH3), 37.3 (C-7),
39.0 (C-4), 42.3 (C-7a), 44.1 (C-3a), 55.2 (OCH3), 109.8 (C-3′), 113.8
(C-3′′,5′′), 117.9 (C-6′), 123.7 (C-4′a), 125.0 (C-6), 125.4 (C-6′), 125.9
(C-5′), 129.2 (C-1′′), 129.9 (C-2′′,6′′), 132.6 (C-5), 133.9 (C-7′), 156.7
(C-8′a), 159.0 (C-4′′), 167.9 (C-2′), 176.5, 177.4 (C-1 and C-3), 178.2
(C-4′) ppm.
General Procedure for the Synthesis of 2-Methyl-7-(4-oxo-4H-
chromen-2-yl)-4-aryl-3a,4,5,7a-tetrahydro-1H-isoindole-
1,3(2H)-diones 5a–5e: NMM (40.3 mg, 0.363 mmol), Sc(OTf)3
(59.5 mg, 0.121 mmol), and the appropriate chromone 3a–3e
(0.121 mmol) were mixed in a closed vessel. The resulting mixture
was heated at 165 °C under MV irradiation (monomode apparatus)
for 10 min. The residue was dissolved in dichloromethane and puri-
fied by preparative TLC with ethyl acetate/hexane (1:1) as the elu-
ent.
2-Methyl-7-(4-oxo-4H-chromen-2-yl)-4-phenyl-3a,4,5,7a-tetra-
hydro-1H-isoindole-1,3(2H)-dione (5a): Yield 36 mg (77 %), white
solid, m.p. 220–223 °C. 1H NMR (300 MHz, CDCl3): δ = 2.59 (s, 3 H,
NCH3), 2.76–2.82 (m, 2 H, 5-H), 3.49 (q, J = 5.8 Hz, 1 H, 4-H), 3.60
(dd, J = 7.9, 5.8 Hz, 1 H, 3a-H), 4.15 (dd, J = 7.9, 1.5 Hz, 1 H, 7a-H),
6.65 (s, 1 H, 3′-H), 7.24–7.33 (m, 5 H, 2′′,3′′,4′′,5′′,6′′-H, 6-H), 7.41
(ddd, J = 8.0, 7.1, 0.8 Hz, 1 H, 6′-H), 7.48 (dd, J = 8.5, 0.8 Hz, 1 H, 8′-
H), 7.68 (ddd, J = 8.5, 7.1, 1.6 Hz, 1 H, 7′-H), 8.21 (dd, J = 8.0, 1.6 Hz,
1 H, 5′-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 24.4 (NCH3), 28.5
(C-5), 38.2 (C-4), 40.6 (C-7a), 45.2 (C-3a), 109.0 (C-3′), 117.9 (C-8′),
124.0 (C-4′a), 125.2 (C-6), 125.7 (C-6′), 126.8 (C-5′), 127.5 (C-7), 128.0
(C-2′′,6′′), 128.5 (C-3′′, 5′′), 133.8 (C-7′), 135.9 (C-4′′), 139.4 (C-1′′),
156.0 (C-8′a), 161.9 (C-2′), 174.0 (C-1), 176.3 (C-3), 178.5 (C-4′) ppm.
EI-MS: m/z (%) = 386 (24) [M + H]+, 385 (100) [M]+·, 274 (21), 273
(34). EI-HRMS: calcd. for C24H19NO4 [M]+ 385.1314; found 385.1319.
4-(4-Chlorophenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)-
3a,4,5,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (5b): Yield
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28 mg (55 %), white solid, m.p. 209–211 °C. 1H NMR (300 MHz,
CDCl3): δ = 2.68 (s, 3 H, NCH3), 2.68–2.79 (m, 2 H, 5-H), 3.42 (dt, J =
7.8, 5.4 Hz, 1 H, 4-H), 3.59 (dd, J = 8.1, 5.4 Hz, 1 H, 3a-H), 4.19 (dd,
J = 8.1, 1.7 Hz, 1 H, 7a-H), 6.65 (s, 1 H, 3′-H), 7.21 (d, J = 8.6 Hz, 2
H, 3′′,5′′-H), 7.20–7.24 (m, 1 H, 6-H), 7.29 (d, J = 8.6 Hz, 2 H, 2′′,6′′-
H), 7.41 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H, 6′-H), 7.47 (dd, J = 8.5, 1.0 Hz,
1 H, 8′-H), 7.69 (ddd, J = 8.5, 7.1, 1.7 Hz, 1 H, 7′-H), 8.22 (dd, J = 8.0,
1.7 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.5 (NCH3),
28.1 (C-5), 37.8 (C-4), 40.9 (C-7a), 45.0 (C-3a), 109.2 (C-3′), 117.8
(C-8′), 124.0 (C-4′a), 125.2 (C-6′), 125.8 (C-5′), 127.0 (C-7), 128.6
(C-2′′,6′′), 129.3 (C-3′′,5′′), 133.3 (C-1′′), 133.9 (C-7′), 135.5 (C-6), 138.0
(C-4′′), 156.0 (C-8′a), 161.6 (C-2′), 173.9 (C-3), 176.0 (C-1), 178.4
(C-4′) ppm. EI-MS: m/z (%) = 421 (37Cl, 23) [M]+·, 419 (35Cl, 100)
[M]+·. EI-HRMS m/z calcd. for C24H1835ClNO4 [M]+ 419.0924; found
419.0938.
4-(4-Methoxyphenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)-
3a,4,5,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (5c): Yield
34 mg (67 %), white solid, m.p. 222–224 °C. 1H NMR (300 MHz,
CDCl3): δ = 2.60 (s, 3 H, NCH3), 2.73–2.80 (m, 2 H, 5-H), 3.46 (q, J =
5.7 Hz, 1 H, 4-H), 3.55 (dd, J = 7.8, 5.7 Hz, 1 H, 3a-H), 3.77 (s, 3 H,
OCH3), 4.12 (dd, J = 7.8, 1.4 Hz, 1 H, 7a-H), 6.63 (s, 1 H, 3′-H), 6.82
(d, J = 8.7 Hz, 2 H, 3′′,5′′-H), 7.17 (d, J = 8.7 Hz, 2 H, 2′′,6′′-H), 7.24
(td, J = 4.8, 1.4 Hz, 1 H, 6-H), 7.40 (ddd, J = 7.7, 7.3, 0.8 Hz, 1 H, 6′-
H), 7.47 (dd, J = 8.3, 0.8 Hz, 1 H, 8′-H), 7.68 (ddd, J = 8.3, 7.3, 1.6 Hz,
1 H, 7′-H), 8.21 (dd, J = 7.7, 1.6 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 24.4 (NCH3), 29.0 (C-5), 37.5 (C-4), 40.4 (C-7a), 45.2
(C-3a), 55.2 (OCH3), 109.0 (C-3′), 113.8 (C-3′′,5′′), 117.9 (C-8′), 124.0
(C-4′a), 125.1 (C-6′), 125.7 (C-5′), 126.7 (C-7), 129.1 (C-2′′,6′′), 131.2
(C-1′′), 133.8 (C-7′), 135.9 (C-6), 156.0 (C-8′a), 158.8 (C-4′′), 162.0 (C-
2′), 174.1 (C-1), 176.5 (C-3), 178.5 (C-4′) ppm. EI-MS: m/z (%) = 415
(5) [M]+·, 385 (26), 381 (100), 353 (27), 352 (22). EI-HRMS: calcd. for
C25H21NO5 [M]+ 415.1420; found 415.1427.
2-Methyl-7-(4-oxo-4H-chromen-2-yl)-4-(4-methylphenyl)-
3a,4,5,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (5d): Yield
34 mg (71 %), white solid, m.p. 223–225 °C. 1H NMR (300 MHz,
CDCl3): δ = 2.31 (s, 3 H, CH3), 2.61 (s, 3 H, NCH3), 2.73–2.80 (m, 2 H,
5-H), 3.45 (q, J = 5.7 Hz, 1 H, 4-H), 3.57 (dd, J = 7.9, 5.7 Hz, 1 H, 3a-
H), 4.14 (dd, J = 7.9, 1.4 Hz, 1 H, 7a-H), 6.65 (s, 1 H, 3′-H), 7.10, 7.15
(J = 8.5 Hz, 4 H, 3′′,5′′-H; 2′′,6′′-H, AA′BB′), 7.23–7.26 (m, 1 H, 6-H),
7.41 (ddd, J = 7.7, 7.3, 1.0 Hz, 1 H, 6′-H), 7.47 (dd, J = 8.2, 1.0 Hz, 1
H, 8′-H), 7.68 (ddd, J = 8.2, 7.3, 1.6 Hz, 1 H, 7′-H), 8.21 (dd, J = 7.7,
1.6 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 21.0 (CH3),
24.4 (NCH3), 28.5 (C-5), 37.9 (C-4), 40.6 (C-7a), 45.2 (C-3a), 109.0 (C-
3′), 117.9 (C-8′), 124.0 (C-4′a), 125.1 (C-6′), 125.7 (C-5′), 126.7 (C-7),
127.8 (C-2′′,6′′), 129.1 (C-3′′,5′′), 133.8 (C-7′), 136.0 (C-6), 136.3
(C-1′′), 137.1 (C-4′′), 156.0 (C-8′a), 162.0 (C-2′), 174.1 (C-1), 176.3
(C-3), 178.5 (C-4′) ppm. EI-MS: m/z (%) = 400 (23) [M + H]+, 399
(100) [M]+·, 395 (26), 287 (32). EI-HRMS: calcd. for C25H21NO4 [M]+
399.1471; found 399.1476.
2-Methyl-4-(4-nitrophenyl)-7-(4-oxo-4H-chromen-2-yl)-
3a,4,5,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (5e): Yield
27 mg (52 %), white solid, m.p. 162–165 °C. 1H NMR (300 MHz,
CDCl3): δ = 2.78 (s, 3 H, NCH3), 2.73–2.82 (m, 2 H, 5-H), 3.46 (dt, J =
9.8, 5.1 Hz, 1 H, 4-H), 3.71 (ddd, J = 8.1, 5.1, 1.3 Hz, 1 H, 3a-H), 4.31
(d, J = 8.1 Hz, 1 H, 7a-H), 6.70 (s, 1 H, 3′-H), 7.23 (ddd, J = 6.3, 3.5,
1.1 Hz, 1 H, 6-H), 7.42 (ddd, J = 8.1, 7.1, 1.1 Hz, 1 H, 6′-H), 7.44–7.49
(m, 1 H, 8′-H), 7.50 (d, J = 8.6 Hz, 2 H, 2′′,6′′-H), 7.70 (ddd, J = 8.7,
7.1, 1.7 Hz, 1 H, 7′-H), 8.20–8.23 (m, 1 H, 5′-H), 8.22 (d, J = 8.6 Hz, 2
H, 3′′,5′′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.8 (NCH3), 26.9
(C-5), 38.5 (C-4), 41.6 (C-7a), 45.0 (C-3a), 109.4 (C-3′), 117.8 (C-8′),
123.6 (C-3′′,5′′), 123.9 (C-4′a), 125.3 (C-6′), 125.8 (C-5′), 127.5 (C-7),
128.8 (C-2′′,6′′), 134.0 (C-7′), 135.0 (C-6), 147.1 (C-4′′), 147.4 (C-1′′),
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155.9 (C-8′a), 161.1 (C-2′), 173.6 (C-1), 175.5 (C-3), 178.4 (C-4′) ppm.
EI-MS: m/z (%) = 430 (62) [M]+·, 400 (100), 396 (50), 383 (30), 368
(34). EI-HRMS: calcd. for C24H18N2O6 [M]+ 430.1165; found 430.1161.
(E)-4-(4-Methoxystyryl)-2-methyl-3a,4,5,11b-tetrahydrochrom-
eno[3,2-e]isoindole-1,3,11(2H)-trione (6c): This compound was
isolated from the reaction of 3c (37 mg, 0.121 mmol) with NMM
(67 mg, 0.605 mmol) in dry DMF (10 μL) at 160 °C for 10 min in a
multimode MV apparatus, and the residue was purified by prepara-
tive TLC with ethyl acetate/hexane (1:1) as the eluent. Yield 3 mg
(6 %). 1H NMR (500 MHz, CDCl3): δ = 2.73 (dd, J = 17.3, 7.4 Hz, 1 H,
5-H), 2.87 (s, 3 H, NCH3), 2.95 (dd, J = 17.3, 4.2 Hz, 1 H, 5-H), 3.11–
3.16 (m, 1 H, 4-H), 3.37 (dd, J = 8.2, 5.3 Hz, 1 H, 3-Ha), 3.79 (s, 3 H,
OCH3), 4.55 (d, J = 8.2 Hz, 1 H, 11b-H), 6.19 (dd, J = 15.7, 9.3 Hz, 1
H, α-H), 6.49 (d, 1 H, H-, J = 15.7 Hz), 6.82 (d, 2 H, H-3′,5′, J =
8.6 Hz), 7.25 (d, 2 H, H-2′,6′, J = 8.6 Hz), 7.41–7.44 (m, 2 H, H-7, H-
9), 7.67 (ddd, 1 H, H-8, J = 8.2, 7.3, 1.4 Hz), 8.29 (dd, 1 H, H-10, J =
7.9, 1.4 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ = 24.8 (NCH3), 32.5
(C-5), 38.1 (C-11b), 39.0 (C-4), 44.5 (C-3a), 55.3 (OCH3), 112.8 (C-11a),
114.1 (C-3′,5′), 117.7 (C-7), 123.6 (C-α), 123.9 (C-10a), 125.3 (C-9),
126.4 (C-10), 127.7 (C-2′,6′), 129.0 (C-1′), 132.3 (C-), 133.8 (C-8),
155.7 (C-6a), 159.5 (C-4′), 163.6 (C-5a), 175.1 (C-3), 176.0 (C-11), 176.5
(C-1) ppm.
Bisadduct 7c was isolated as a mixture of diastereomers from the
reac t ion of 3c (37 mg, 0 .121 mmol ) wi th NMM (202 mg,
1.815 mmol) in dry DMF (10 μL) at 160 °C in a multimode MV
apparatus, and the residue was purified by preparative TLC with
ethyl acetate/hexane (4:1) as the eluent. Further purification of the
mixture of diastereomers by preparative TLC with dichloromethane/
ethyl acetate (10:2) as the eluent afforded diastereomer I. Diastereo-
mer II was characterized by 1H and 13C NMR spectroscopy with a
mixture with diastereomer I (enriched in diastereomer II).
rel-(3aR,4R,5aR,5bR,8aR,14bS,14cS)-4-(4-Methoxyphenyl)-2,7-
dimethyl-3a,4,5,5a,5b,8a,14b,14c-octahydro-1H-chromeno-
[3,2-e]isoindolo[4,5-g]isoindole-1,3,6,8,9(2H,7H)-pentaone (7c,
Diastereomer I): White solid, m.p. 230–232 °C. 1H NMR (300 MHz,
CDCl3): δ = 1.98–2.11 (m, 1 H, 5-H), 2.25–2.36 (m, 1 H, 5a-H), 2.79–
2.84 (m, 1 H, 5-H), 2.93, 2.94 (2s, 3 H, 2- and 7-NCH3), 3.24 (ddd, J =
12.5, 4.0, 1.2 Hz, 1 H, 14b-H), 3.36 (dd, J = 8.7, 4.9 Hz, 1 H, 5b-H),
3.49 (dd, J = 9.3, 6.2 Hz, 1 H, 3a-H), 3.61–3.69 (m, 1 H, 4-H), 3.82 (s,
3 H, OCH3), 4.14 (dd, J = 9.3, 4.0 Hz, 1 H, 14c-H), 4.72 (dd, J = 8.7,
1.3 Hz, 1 H, 8a-H), 6.92 (d, J = 8.6 Hz, 2 H, 3′,5′-H), 7.16 (d, J = 8.6 Hz,
2 H, 2′,6′-H), 7.39 (d, J = 8.3 Hz, 1 H, 13-H), 7.39–7.44 (m, 1 H, 11-
H), 7.66 (ddd, J = 8.3, 7.2, 1.7 Hz, 1 H), 8.29 (dd, J = 8.0, 1.7 Hz, 1 H,
10-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.8, 25.1 (2- and 7-NCH3),
25.5 (C-5), 31.6 (C-5a), 33.7 (C-14b), 37.0 (C-4), 39.3 (C-8a), 40.3 (C-
14c), 43.3 (C-5b), 45.7 (C-3a), 55.2 (OCH3), 113.7 (C-8b and C-3′,5′),
117.5 (C-11), 123.4 (C-9a), 125.4 (C-13), 126.4 (C-10), 128.7 (C-2′,6′),
131.4 (C-1′), 133.9 (C-12), 155.2 (C-13a), 158.6 (C-4′), 164.0 (C-14a),
174.7, 177.0 (C-6 and C-8), 175.9, 176.1 (C-1, C-3, and C-9) ppm. EI-
MS: m/z (%) = 527 (26) [M + H]+, 526 (100) [M]+·, 414 (39), EI-HRMS:
calcd. for C30H26N2O7 [M]+ 526.1740; found 526.1754.
rel-(3aR,4R,5aS,5bS,8aS,14bS,14cS)-4-(4-Methoxyphenyl)-2,7-di-
methyl-3a,4,5,5a,5b,8a,14b,14c-octahydro-1H-chromeno-
[3,2-e]isoindolo[4,5-g]isoindole-1,3,6,8,9(2H,7H)-pentaone (7c,
Diastereomer II): 1H NMR (500 MHz, CDCl3): δ = 2.17–2.20 (m, 1 H,
5-H), 2.89–2.94 (m, 1 H, 5a-H), 2.89, 2.93 (2s, 3 H, 2- and 7-NCH3),
3.30 (t, J = 8.3 Hz, 1 H, 5b-H), 3.41–3.52 (m, 3 H, 5-H, 4-H, 14b-H),
3.55 (dd, J = 7.8, 5.9 Hz, 1 H, 3a-H), 3.74–3.79 (m, 1 H, 14c-H), 3.83
(s, 3 H, OCH3), 4.64 (dd, J = 8.9, 1.2 Hz, 1 H, 8a-H), 6.94 (d, J = 8.8 Hz,
2 H, 3′,5′-H), 7.21 (d, J = 8.8 Hz, 2 H, 2′,6′-H), 7.35 (d, J = 7.9 Hz, 1
H, 13-H), 7.39–7.44 (m, 1 H, 11-H), 7.62–7.70 (m, 1 H, 12-H), 8.28 (dd,
J = 8.0, 1.3 Hz, 1 H, 10-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 23.8
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(C-5), 25.1, 25.3 (2- and 7-NCH3), 31.7 (C-5a), 35.5 (C-3a), 38.3 (C-8a),
38.8 (C-4), 39.3 (C-5b), 40.7 (C-14c), 45.6 (C-14b), 55.2 (OCH3), 113.7
(C-3′,5′), 114.8 (C-8b), 117.2 (C-11), 123.5 (C-9a), 125.2 (C-13), 126.6
(C-10), 128.8 (C-2′,6′), 131.9 (C-1′), 133.9 (C-12), 155.4 (C-13a), 158.6
(C-4′), 161.6 (C-14a), 174.0, 177.6 (C-6 and C-8), 175.8, 175.9, 176.2
(C-1, C-3, and C-9) ppm.
4-(4-Methoxyphenyl)-7-(4-oxo-4H-chromen-2-yl)-2-phenyl-
3a,4,5,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (8): N-Phenyl-
maleimide (62.8 mg, 0.363 mmol), Sc(OTf)3 (59.5 mg, 0.121 mmol),
and 3c (0.121 mmol) were mixed in a closed vessel. The resulting
mixture was heated at 165 °C under MV irradiation (monomode
apparatus) for 10 min. The residue was dissolved in dichloro-
methane and purified by preparative TLC with ethyl acetate/hexane
(1:1) as the eluent. Yield 38 mg (66 %), white solid, m.p. 212–214 °C.
1H NMR (300 MHz, CDCl3): δ = 2.78–2.93 (m, 2 H, 5-H), 3.54–3.74
(m, 2 H, 3a-H, 4-H), 3.75 (s, 3 H, OCH3), 4.28 (dd, J = 7.1, 1.7 Hz, 1
H, 7a-H), 6.62–6.65 (m, 1 H, 6-H), 6.64 (s, 1 H, 3′-H), 6.81 (d, J =
8.7 Hz, 2 H, 3′′,5′′-H), 7.22 (d, J = 8.7 Hz, 2 H, 3′′,5′′-H), 7.24–7.30 (m,
5 H, 2′′′,3′′′,4′′′,5′′′,6′′′-H), 7.39 (ddd, J = 7.9, 7.1, 1.0 Hz, 1 H, 6′-H),
7.47 (dd, J = 8.6, 1.0 Hz, 1 H, 8′-H), 7.67 (ddd, J = 8.6, 7.1, 1.7 Hz, 1
H, 7′-H), 8.20 (dd, J = 7.9, 1.7 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 30.0 (C-5), 37.2 (C-4), 39.9 (C-7a), 44.8 (C-3a), 55.3 (OCH3),
108.9 (C-3′), 114.2 (C-3′′,5′′), 117.9 (C-8′), 124.0 (C-4′a), 125.1 (C-6′),
125.7 (C-5′), 126.2 (C-2′′′ ,6′′′), 126.5 (C-6), 128.5 (C-7), 128.8
(C-3′′′,5′′′), 129.5 (C-2′′,6′′), 131.0 (C-1′′′), 131.3 (C-1′′), 133.8 (C-7′),
135.8 (C-4′′′), 156.0 (C-8′a), 159.2 (C-4′′), 162.3 (C-2′), 173.0 (C-1),
175.6 (C-3), 178.4 (C-4′) ppm. EI-MS: m/z (%) = 478 (23) [M + H]+,
477 (81) [M]+·, 474 (100), 473 (29), 445 (36), 444 (45), 305 (23). EI-
HRMS: calcd. for C30H23NO5 [M]+ 477.1576; found 477.1590.
Dialkyl 4′-Methoxy-4-(4-oxo-4H-chromen-2-yl)-[1,1′-biphenyl]-
2,3-dicarboxylates 9a and 9b: Dimethyl acetylenedicarboxylate
(45 μL, 0.363 mmol) or diethyl acetylenedicarboxylate (58 μL,
0.363 mmol) and chromone 3c (37 mg, 0.121 mmol) were mixed in
a closed vessel. The resulting mixture was heated at 165 °C under
MV irradiation (monomode apparatus) for 15 min. The residue was
dissolved in dichloromethane and purified by preparative TLC with
ethyl acetate/hexane (1:1) as the eluent.
Dimethyl 4′-Methoxy-4-(4-oxo-4H-chromen-2-yl)-[1,1′-bi-
phenyl]-2,3-dicarboxylate (9a): Yield 16 mg (30 %), yellow solid,
m.p. 226–227 °C. 1H NMR (300 MHz, CDCl3): δ = 3.69, 3.76 (2 × s,
2 × 3 H, 2,3-CO2CH3), 3.86 (s, 3 H, 4′′-OCH3), 6.64 (s, 1 H, 3′-H), 6.97
(d, J = 8.7 Hz, 2 H, 3′′,5′′-H), 7.31 (d, J = 8.7 Hz, 2 H, 2′′,6′′-H), 7.42
(d, J = 8.1 Hz, 1 H, 8′-H), 7.45 (td, J = 7.7, 1.0 Hz, 1 H, 6′-H), 7.60 (d,
J = 8.1 Hz, 1 H, 6-H), 7.67–7.73 (m, 1 H, 7′-H), 7.74 (d, J = 8.1 Hz, 1
H, 5-H), 8.25 (dd, J = 8.1, 1.5 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 52.7, 53.1 (2,3-CO2CH3), 55.3 (4′′-OCH3), 110.9 (C-3′),
114.1 (C-3′′,5′′), 117.7 (C-8′), 123.8 (C-4′a), 125.6 (C-6′), 125.9 (C-5′),
129.4 (C-2′′,6′′), 130.3 (C-5), 130.4 (C-4), 131.0 (C-1′′), 131.4 (C-3),
132.4 (C-6), 133.3 (C-2), 134.1 (C-7′), 143.2 (C-1), 156.3 (C-8′a), 159.8
(C-4′′), 163.6 (C-2′), 167.6, 168.2 (2,3-CO2CH3), 178.0 (C-4′) ppm. EI-
MS: m/z (%) = 445 (20) [M + H]+, 444 (100) [M]+·, 413 (36). EI-HRMS:
calcd. for C26H20O7 [M]+ 444.1209; found 444.1214.
Diethyl 4′-Methoxy-4-(4-oxo-4H-chromen-2-yl)-[1,1′-biphenyl]-
2,3-dicarboxylate (9b): Yield 20 mg (35 %), yellow solid, m.p. 170–
172 °C. 1H NMR (300 MHz, CDCl3): δ = 1.078, 1.083 (2 × 3t, J = 7.2 Hz,
2 × 3 H, 2- and 3-CO2CH2CH3), 3.86 (s, 3 H, OCH3), 4.14 (q, J = 7.2 Hz,
2 H, 2-CO2CH2CH3), 4.21 (q, J = 7.2 Hz, 2 H, 3-CO2CH2CH3), 6.63 (s,
1 H, 3′-H), 6.96 (d, J = 8.7 Hz, 2 H, 3′′,5′′-H), 7.32 (d, J = 8.7 Hz, 2 H,
2′′,6′′-H), 7.42 (d, J = 8.4 Hz, 1 H, 8′-H), 7.45 (ddd, J = 8.0, 7.2, 1.2 Hz,
1 H, 6′-H), 7.58 (d, J = 8.0 Hz, 1 H, 6-H), 7.70 (ddd, J = 8.4, 7.2, 1.7 Hz,
1 H, 7′-H), 7.72 (d, J = 8.0 Hz, 1 H, 5-H), 8.26 (dd, J = 8.0, 1.7 Hz, 1
H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.7, 13.8 (2,3-
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CO2CH2CH3), 55.4 (OCH3), 61.8 (2-CO2CH2CH3), 62.3 (3-CO2CH2CH3),
111.0 (C-3′), 114.0 (C-3′′,5′′), 117.8 (C-8′), 123.8 (C-4′a), 125.5 (C-6′),
125.9 (C-5′), 129.5 (C-2′′,6′′), 130.2 (C-5), 130.5 (C-4), 131.2 (C-1′′),
131.5 (C-3), 132.3 (C-6), 133.8 (C-2), 134.1 (C-7′), 143.2 (C-1), 156.3
(C-8′a), 159.8 (4′′), 163.9 (C-2′), 167.0 (3-CO2CH2CH3), 167.7 (2-
CO2CH2CH3), 178.0 (C-4′) ppm. EI-MS: m/z (%) = 473 (20) [M + H]+,
472 (100) [M]+·, 399 (91), 327 (21). EI-HRMS: calcd. for C28H24O7 [M]+
472.1522; found 472.1524.
Dialkyl 3-(4-Methoxyphenyl)-6-(4-oxo-4H-chromen-2-yl)-3,6-di-
hydropyridazine-1,2-dicarboxylates 10a and 10b: Diethyl azodi-
carboxylate toluene solution (0.14 mL, 0.363 mmol) or diisopropyl
azodicarboxylate (71 μL, 0.363 mmol) and chromone 3c (37 mg,
0.121 mmol) were mixed in a closed vessel. The resulting mixture
was heated at 165 °C under MV irradiation (monomode apparatus)
for 15 or 10 min, respectively. The residue was dissolved in dichloro-
methane and purified by preparative TLC with ethyl acetate/hexane
(1:1) as the eluent.
Diethyl 3-(4-Methoxyphenyl)-6-(4-oxo-4H-chromen-2-yl)-3,6-di-
hydropyridazine-1,2-dicarboxylate (10a): Yield 13 mg (22 %), col-
orless oil. 1H NMR (300 MHz, CDCl3): δ = 0.71–0.77 (m, 6 H, 1,2-
CO2CH2CH3), 3.56–3.95 (m, 4 H, 1,2-CO2CH2CH3), 3.80 (s, 3 H, OCH3),
5.87–5.90 (m, 2 H, 3-H, 6-H), 6.21–6.24 (m, 1 H, 4-H), 6.28–6.31 (m,
1 H, 5-H), 6.45 (s, 1 H, 3′-H), 6.86 (d, J = 8.6 Hz, 2 H, 3′′,5′′-H), 7.32
(d, J = 8.6 Hz, 2 H, 2′′,6′′-H), 7.40 (ddd, J = 8.0, 7.1, 1.1 Hz, 1 H, 6′-
H), 7.49 (d, J = 8.3 Hz, 1 H, 8′-H), 7.67 (ddd, J = 8.3, 7.1, 1.7 Hz, 1 H,
7′-H), 8.18 (dd, J = 8.0, 1.7 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 13.8, 13.9 (1,2-CO2CH2CH3), 53.8 (C-6), 54.8 (C-3), 55.4
(OCH3), 62.3, 62.5 (1,2-CO2CH2CH3), 111.1 (C-3′), 113.8 (C-3′′,5′′),
118.2 (C-8′), 121.9 (C-4), 123.8 (C-4′a), 125.3 (C-6′), 125.7 (C-5′), 129.4
(C-1′′), 129.5 (C-5), 129.8 (C-2′′,6′′), 133.9 (C-7′), 154.9, 155.5 (1,2-
CO2CH2CH3), 156.4 (C-8′a), 159.7 (C-4′′), 163.8 (C-2′), 178.2 (C-4′)
ppm. EI-MS: m/z (%) = 478 (17) [M]+·, 405 (54), 390 (33), 389 (86),
318 (75), 317 (54), 303 (100), 197 (69). EI-HRMS: calcd. for
C26H26N2O7 [M]+ 478.1740; found 478.1745.
Diisopropyl 3-(4-Methoxyphenyl)-6-(4-oxo-4H-chromen-2-yl)-
3,6-dihydropyridazine-1,2-dicarboxylate (10b): Yield 35 mg
(57 %), yellow oil. 1H NMR (300 MHz, CDCl3): δ = 0.530, 0.97 (2 × d,
J = 6.2 Hz, 2 × 3 H, 4′′′′,5′′′′-CH3), 0.531, 1.03 (2 × d, J = 6.2 Hz, 2 × 3
H, 4′′′,5′′′-CH3), 3.79 (s, 3 H, 4′′-OCH3), 4.60 (sept, J = 6.3 Hz, 1 H,
3′′′-H), 4.71 (sept, J = 6.3 Hz, 1 H, 3′′′′-H), 5.87–5.92 (m, 2 H, 3-H, 6-
H), 6.19–6.32 (m, 2 H, 4-H, 5-H), 6.86 (d, J = 8.7 Hz, 2 H, 3′′,5′′-H),
7.33 (d, J = 8.7 Hz, 2 H, 2′′,6′′-H), 7.40 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H,
6′-H), 7.50 (dd, J = 8.6, 1.0 Hz, 1 H, 8′-H), 7.67 (ddd, J = 8.6, 7.1,
1.7 Hz, 1 H, 7′-H), 8.18 (dd, J = 8.0, 1.7 Hz, 1 H, 5′-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 20.9, 21.2 (5′′′′- and 4′′′′-CH3), 21.81, 21.83 (5′′′-
and 4′′′-CH3), 53.5 (C-6), 54.5 (C-6), 55.4 (4′′-OCH3), 69.9 (C-3′′′′), 70.3
(C-3′′′), 111.2 (C-3′), 113.8 (C-3′′,5′′), 118.3 (C-8′), 121.8 (C-4 or C-5),
123.9 (C-4′a), 125.3 (C-6′), 125.6 (C-5′), 129.6, 129.7 (C-1 and C-4 or
C-5), 129.8 (C-2′′,6′′), 133.9 (C-7′), 154.4 (C-1′′′′), 154.8 (C-1′′′), 156.4
(C-8′a), 159.7 (C-4′′), 163.9 (C-2′), 178.2 (C-4′) ppm. EI-MS: m/z (%) =
506 (5) [M]+·, 420 (67), 403 (28), 333 (42), 318 (71), 317 (100), 316
(21), 305 (89), 303 (63), 302 (34), 197 (39). EI-HRMS: calcd. for
C28H30N2O7 [M]+ 506.2053; found 506.2061.
4-[1,2-Bis(ethoxycarbonyl)hydrazinyl]-3-(4-methoxyphenyl)-6-
(4-oxo-4H-chromen-2-yl)-3,4-dihydropyridazine-1,2-dicarboxyl-
ate (11): Diethyl azodicarboxylate solution (0.14 mL, 0.363 mmol)
and 3c (37 mg, 0.121 mmol) were mixed in a closed vessel. The
resulting mixture was heated at 130 °C under MV irradiation (mono-
mode apparatus) for 10 min. The residue was dissolved in dichloro-
methane and purified by preparative TLC with ethyl acetate/hexane
(1:1) as the eluent. Yield 24 mg (30 %), yellow solid, m.p. 110–112 °C.
1H NMR (500 MHz, [D6]DMSO, 80 °C): δ = 0.81, 1.10 (2 × t, J = 7.0 Hz,
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2 × 3 H, 2 × CH3), 1.14–1.17 (m, 3 H, CH3), 1.25 (t, J = 7.0 Hz, 3 H,
CH3), 3.66–3.83 (m, 2 H, CH2), 3.75 (s, 3 H, OCH3), 4.01–4.09 (m, 4 H,
CH2), 4.13–4.20 (m, 2 H, CH2), 5.07 (br s, 1 H, 3-H), 5.70 (br s, 1 H, 4-
H), 6.49 (s, 1 H, 3′-H), 6.53 (br s, 1 H, 5-H), 6.92 (d, J = 8.5 Hz, 2 H,
3′′,5′′-H), 7.27 (d, J = 8.5 Hz, 2 H, 2′′,6′′-H), 7.50 (ddd, J = 8.0, 7.2,
1.0 Hz, 1 H, 6′-H), 7.61 (dd, J = 8.0, 1.0 Hz, 1 H, 8′-H), 7.82 (ddd, J =
8.6, 7.2, 1.7 Hz, 1 H, 7′-H), 8.05 (dd, J = 8.0, 1.7 Hz, 1 H, 5′-H), 9.07
(br s, 1 H, NH) ppm. 13C NMR (125 MHz, [D6]DMSO, 80 °C): δ = 13.2
(CH3), 13.7 (CH3), 13.81 (CH3), 13.83 (CH3), 54.9 (OCH3 and C-3), 60.7
(CH2), 61.8 (CH2), 62.0 (CH2), 62.2 (CH2 and C-4), 107.9 (C-3′), 113.7
(C-3′′,5′′), 117.8 (C-8′), 121.2 (C-5), 123.1 (C-4′a), 124.5 (C-5′), 125.3
(C-6′), 128.5 (C-2′′,6′′), 129.4 (C-1′′), 134.1 (C-7′), 136.0 (C-6), 152.4
( CO 2 ) , 1 5 3 . 3 ( CO 2 ) , 1 5 4 . 3 ( CO 2 ) , 1 5 4 . 4 ( CO 2 ) , 1 5 5 . 1
(C-8′a), 158.2 (C-2′), 159.0 (C-4′′), 176.3 (C-4′) ppm. EI-MS: m/z (%) =
652 (1) [M]+·, 405 (96), 372 (74), 359 (50), 331 (96), 225 (77), 208
(100). EI-HRMS: calcd. for C32H36N4O11 [M]+ 652.2381; found
652.2386.
General Procedure for the Synthesis of 4-(4-Oxo-4H-chromen-2-
yl)-7-arylisoindoline-1,3-diones 12a–12e and 14: DDQ (65.4 mg,
0.288 mmol) was added to a solution of the appropriate adduct
5a–5e and 8 (0.072 mmol) in 1,2,4-TCB (0.5 mL). The mixture was
heated at 165 °C under MV irradiation (monomode apparatus) for
25 min. The residue was treated with a sodium hydrogen carbonate
aqueous solution (20 mL), and the aqueous layer was extracted
with dichloromethane (3 × 50 mL). The organic layer was dried with
anhydrous sodium sulfate, and the solvent was evaporated to dry-
ness. The residue was purified by preparative TLC with hexane fol-
lowed by ethyl acetate/hexane (9:7) as the eluent.
2-Methyl-4-(4-oxo-4H-chromen-2-yl)-7-phenylisoindoline-1,3-
dione (12a): Yield 23 mg (85 %), white solid, m.p. 243–245 °C. 1H
NMR (300 MHz, CDCl3): δ = 3.15 (s, 3 H, NCH3), 6.76 (s, 1 H, 3′-H),
7.47 (ddd, J = 8.0, 7.0, 1.0 Hz, 1 H, 6′-H), 7.49–7.59 (m, 6 H, 2′′,3′′,4′′
,5′′,6′′-H; 8′-H), 7.73 (ddd, J = 8.5, 7.0, 1.7 Hz, 1 H, 7′-H), 7.77 (d, J =
8.0 Hz, 1 H, 5-H), 7.93 (d, J = 8.0 Hz, 1 H, 6-H), 8.29 (dd, J = 8.0,
1.7 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.1 (NCH3),
112.7 (C-3′), 118.2 (C-8′), 124.0 (C-4′a), 125.5 (C-6′), 125.8 (C-5′), 128.2
(C-2′′,6′′), 129.0 (C-3a), 129.2 (C-4′′), 129.4 (C-3′′,5′′ and C-7), 130.6
(C-7a), 133.9 (C-6), 134.2 (C-7′), 135.5 (C-1′′), 136.2 (C-5), 143.1 (C-4),
156.6 (C-8′a), 160.9 (C-2′), 165.9, 166.9 (C-1 and C-3), 178.1 (C-4′)
ppm. EI-MS: m/z (%) = 382 [M + H]+ (21), 381 [M]+· (100), 353 (23),
325 (26). EI-HRMS: calcd. for C24H15NO4 [M]+ 381.1001; found
381.1005.
4-(4-Chlorophenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)iso-
indoline-1,3-dione (12b): Yield 22 mg (75 %), white solid, m.p.
214–216 °C. 1H NMR (300 MHz, CDCl3): δ = 3.16 (s, 3 H, NCH3), 6.75
(s, 1 H, 3′-H), 7.44–7.55 (m, 6 H, 6′-H, 8′-H, 2′′,6′′-H, 3′′5′′-H), 7.73
(ddd, J = 8.6, 7.1, 1.7 Hz, 1 H, 7′-H), 7.74 (d, J = 8.0 Hz, 1 H, 5-H),
7.94 (d, J = 8.0 Hz, 1 H, 6-H), 8.28 (dd, J = 8.0, 1.7 Hz, 1 H, 5′-H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 24.2 (NCH3), 112.8 (C-3′), 118.2
(C-8′), 124.0 (C-4′a), 125.5 (C-6′), 125.8 (C-5′), 128.5 (C-3′′,5′′), 129.0
(C-3a), 129.7 (C-7), 130.6 (C-7a), 130.7 (C-2′′,6′′), 133.9 (C-4′′), 134.1
(C-7′), 134.2 (C-6), 135.6 (C-1′′), 136.0 (C-5), 141.7 (C-4), 156.6 (C-8′
a), 160.7 (C-2′), 165.8, 166.8 (C-1 and C-3), 178.0 (C-4′) ppm. EI-MS:
m/z (%) = 417 [M]+· (37Cl, 24), 415 [M]+· (35Cl, 100). EI-HRMS: calcd.
for C24H1435ClNO4 [M]+ 415.0611; found 415.0624.
4-(4-Methoxyphenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)iso-
indoline-1,3-dione (12c): Yield 27 mg (90 %), yellow solid, m.p.
217–219 °C. 1H NMR (300 MHz, CDCl3): δ = 3.16 (s, 3 H, NCH3), 3.90
(s, 3 H, OCH3), 6.75 (s, 1 H, 3′-H), 7.04 (d, J = 8.8 Hz, 2 H, 3′′,5′′-H),
7.46 (td, J = 7.7, 1.0 Hz, 1 H, 6′-H), 7.50–7.52 (m, 1 H, 8′-H), 7.55 (d,
J = 8.8 Hz, 2 H, 2′′,6′′-H), 7.70–7.76 (m, 1 H, 7′-H), 7.75 (d, J = 8.1 Hz,
1 H, 5-H), 7.90 (d, J = 8.1 Hz, 1 H, 6-H), 8.28 (dd, J = 7.7, 1.6 Hz, 1
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H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.1 (NCH3), 55.4
(OCH3), 112.6 (C-3′), 113.7 (C-3′′,5′′), 118.2 (C-8′), 124.0 (C-4′a), 125.4
(C-6′), 125.8 (C-5′), 127.7 (C-1′′), 128.6 (C-3a), 128.8 (C-7), 130.7 (C-
7a), 130.9 (C-2′′,6′′), 133.9 (C-6), 134.1 (C-7′), 136.1 (C-5), 142.9 (C-4),
156.6 (C-8′a), 160.5 (C-4′′), 161.0 (C-2′), 166.0, 167.1 (C-1 and C-3),
178.1 (C-4′) ppm. EI-MS: m/z (%) = 412 [M + H]+ (21), 411 [M]+·
(100). EI-HRMS: calcd. for C25H17NO5 [M]+ 411.1107; found 411.1106.
2-Methyl-4-(4-oxo-4H-chromen-2-yl)-7-(methylphenyl)isoind-
oline-1,3-dione (12d): Yield 23 mg (80 %), white solid, m.p. 221–
223 °C. 1H NMR (300 MHz, CDCl3): δ = 2.45 (s, 3 H, CH3), 3.15 (s, 3
H, NCH3), 6.75 (s, 1 H, 3′-H), 7.32 (d, J = 8.0 Hz, 2 H, 3′′,5′′-H), 7.44–
7.50 (m, 1 H, 6′-H), 7.48 (d, J = 8.0 Hz, 2 H, 2′′,6′′-H), 7.52 (dd, J =
8.8, 1.0 Hz, 1 H, 8′-H), 7.73 (ddd, J = 8.8, 7.1, 1.5 Hz, 1 H, 7′-H), 7.75
(d, J = 8.0 Hz, 1 H, 5-H), 7.91 (d, J = 8.0 Hz, 1 H, 6-H), 8.28 (dd, J =
7.9, 1.5 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3),
24.1 (NCH3), 112.7 (C-3′), 118.2 (C-8′), 124.0 (C-4′a), 125.5 (C-6′),
125.8 (C-5′), 128.9 (C-3a), 129.0 (C-3′′ ,5′′), 129.1 (C-7), 129.3
(C-2′′,6′′), 130.6 (C-7a), 132.6 (C-1′′), 133.9 (C-6), 134.1 (C-7′), 136.2
(C-5), 139.4 (C-4′′), 143.2 (C-4), 156.6 (C-8′a), 161.0 (C-2′), 166.0, 167.0
(C-1 and C-3), 178.1 (C-4′) ppm. EI-MS: m/z (%) = 395 [M]+· (100). EI-
HRMS: calcd. for C25H17NO4 [M]+ 395.1158; found 395.1157.
2-Methyl-4-(4-nitrophenyl)-7-(4-oxo-4H-chromen-2-yl)isoind-
oline-1,3-dione (12e): Yield 21 mg (70 %), yellow solid, m.p. 266–
269 °C. 1H NMR (300 MHz, CDCl3): δ = 3.17 (s, 3 H, NCH3), 6.78 (s, 1
H, 3′-H), 7.48 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H, 6′-H), 7.52 (d, J = 7.0 Hz,
1 H, 8′-H), 7.72–7.78 (m, 1 H, 7′-H), 7.74 (d, J = 8.9 Hz, 2 H, 2′′,6′′-
H), 7.78 (d, J = 8.0 Hz, 1 H, 5-H), 8.01 (d, J = 8.0 Hz, 1 H, 6-H), 8.29
(dd, J = 8.0, 1.2 Hz, 1 H, 5′-H), 8.38 (d, J = 8.9 Hz, 2 H, 3′′,5′′-H) ppm.
13C NMR (75 MHz, CDCl3): δ = 24.3 (NCH3), 113.0 (C-3′), 118.2
(C-8′), 123.4 (C-3′′,5′′), 124.0 (C-4′a), 125.6 (C-6′), 125.9 (C-5′), 129.5
(C-3a), 130.5 (C-2′′,6′′), 130.67, 130.71 (C-7 and C-7a), 134.3 (C-7′, C-
6), 135.7 (C-5), 140.1 (C-4), 141.9 (C-1′′), 148.2 (C-4′′), 156.6 (C-8′a),
160.2 (C-2′), 165.5, 165.6 (C-1 and C-3), 177.9 (C-4′) ppm. EI-MS: m/z
(%) = 426 [M]+· (17), 396 (100). EI-HRMS: calcd. for C24H14N2O6 [M]+
426.0852; found 426.0855.
4-(4-Methoxyphenyl)-7-(4-oxo-4H-chromen-2-yl)-2-phenyliso-
indoline-1,3-dione (14): Yield 29 mg (86 %), white solid, m.p. 271–
272 °C. 1H NMR (300 MHz, CDCl3): δ = 3.88 (s, 3 H, OCH3), 6.75 (s, 1
H, 3′-H), 7.03 (d, J = 8.8 Hz, 2 H, 3′′,5′′-H), 7.35–7.38 (m, 1 H, 4′′′-H),
7.39–7.48 (m, 5 H, 6′-H, 2′′′,6′′′-H, 3′′′,5′′′-H), 7.50 (dd, J = 8.4, 0.6 Hz,
1 H, 8′-H), 7.59 (d, J = 8.8 Hz, 2 H, 2′′,6′′-H), 7.70 (ddd, J = 8.4, 7.2,
1.4 Hz, 1 H, 7′-H), 7.84 (d, J = 8.1 Hz, 1 H, 5-H), 7.96 (d, J = 8.1 Hz,
1 H, 6-H), 8.27 (dd, J = 8.0, 1.4 Hz, 1 H, 5′-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 55.4 (OCH3), 112.7 (C-3′), 113.7 (C-3′′,5′′), 118.3 (C-8′),
124.0 (C-4′a), 125.5 (C-6′), 125.8 (C-5′), 126.7 (C-2′′′,6′′′), 127.6
(C-1′′), 128.0 (C-3a), 128.3 (C-4′′′), 129.0 (C-3′′′,5′′′), 129.3 (C-7), 130.3
(C-7a), 131.0 (C-2′′,6′′), 131.3 (C-1′′′), 134.1 (C-7′), 134.5 (C-6), 136.6
(C-5), 143.5 (C-4), 156.7 (C-8′a), 160.6 (C-4′′), 161.2 (C-2′), 164.9, 166.1
(C-1 and C-3), 178.1 (C-4) ppm. EI-MS: m/z (%) = 477 (100), 473 [M]+·
(95), 444 (54), 222 (77). EI-HRMS: calcd. for C30H19NO5 [M]+ 473.1263;
found 473.1277.
4-(4-Methoxyphenyl)-2-methyl-7-(4-oxo-4H-chromen-2-yl)-
3a,7a-dihydro-1H-isoindole-1,3(2H)-dione (13c): This compound
was obtained as a byproduct in the synthesis of 12c by the same
procedure described above but under classical heating conditions
with toluene and 1,4-dioxane at 100 °C and 1,2,4-TCB at 190 °C.
After a few hours, the oxidation reaction afforded a mixture of the
oxidized product 12c and the semioxidized product 13c. Yield 15–
60 %, m.p. 214–216 °C. 1H NMR (300 MHz, CDCl3): δ = 2.98 (s, 3 H,
NCH3), 3.85 (s, 3 H, OCH3), 4.44 (d, J = 11.6 Hz, 1 H, 7a-H), 4.61 (d,
J = 11.6 Hz, 1 H, 3a-H), 6.45 (dd, J = 6.9, 1.8 Hz, 1 H, 5-H), 6.65 (s, 1
H, 3′-H), 6.95 (d, J = 8.8 Hz, 2 H, 3′′,5′′-H), 7.14 (d, J = 6.9 Hz, 1 H,
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6-H), 7.40 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H, 6′-H), 7.47 (dd, J = 8.5,
1.0 Hz, 1 H, 8′-H), 7.54 (d, J = 8.8 Hz, 2 H, 2′′,6′′-H), 7.67 (ddd, J =
8.5, 7.1, 1.7 Hz, 1 H, 7′-H), 8.20 (dd, J = 8.0, 1.7 Hz, 1 H, 5′-H) ppm.
13C NMR (75 MHz, CDCl3): δ = 25.8 (NCH3), 41.1 (C-7a), 43.7 (C-3a),
55.4 (OCH3), 108.8 (C-3′), 113.9 (C-3′′,5′′), 117.8 (C-8′), 119.9 (C-5),
121.5 (C-7), 124.1 (C-4′a), 125.1 (C-6′), 125.7 (C-5′), 127.9 (C-6), 128.1
(C-2′′,6′′), 129.7 (C-1′′), 133.8 (C-7′), 136.4 (C-4), 156.0 (C-8′a), 160.5
(C-4′′), 161.8 (C-2′), 175.1, 175.3 (C-1 and C-3), 178.3 (C-4′) ppm. EI-
MS: m/z (%) = 414 (24) [M + H]+, 413 (100) [M]+·. EI-HRMS: calcd. for
C25H19NO5 [M]+ 413.1263; found 413.1261.
Diisopropyl [(1Z,3Z)-1-(4-Methoxyphenyl)-4-(4-oxo-4H-
chromen-2-yl)buta-1,3-diene-1,4-diyl]dicarbamate (15b): DDQ
(56.3 mg, 0.248 mmol) was added to a solution of cycloadduct 10b
(63 mg, 0.124 mmol) in 1,2,4-TCB (0.5 mL). The mixture was heated
at 165 °C under MV irradiation (monomode apparatus) for 25 min.
The residue was treated with a sodium hydrogen carbonate aque-
ous solution (10 mL), and the aqueous layer was extracted with
dichloromethane (3 × 15 mL). The organic layer was dried with an-
hydrous sodium sulfate, and the solvent was evaporated to dryness.
The residue was purified by preparative TLC with hexane followed
by dichloromethane/ethyl acetate (10:1) as the eluent. Yield 8.8 mg
(17 %), yellow oil. 1H NMR (500 MHz, [D6]DMSO, 75 °C): δ = 0.82,
0.94, 1.20, 1.25 [4 × d, J = 6.2 Hz, 3 H, CO2CH(CH3)2], 3.78 (s, 3 H,
OCH3), 4.60, 4.84 [2 × sept, J = 6.2 Hz, 1 H, CO2CH(CH3)2], 6.05 (d,
J = 5.9 Hz, 1 H, 2-H), 6.07 (s, 1 H, 1-NH), 6.26 (d, J = 5.9 Hz, 1 H, 3-
H), 6.47 (s, 1 H, 3′-H), 6.95 (d, J = 8.9 Hz, 2 H, 3′′,5′′-H), 7.48–7.51
(m, 2 H, 6′-H, 8′-H), 7.54 (d, J = 8.9 Hz, 2 H, 2′′,6′′-H), 7.83 (ddd, J =
8.7, 7.1, 1.7 Hz, 1 H, 7′-H), 7.88 (br s, 1 H, 4-NH), 8.04 (dd, J = 7.9,
1.7 Hz, 1 H, 8′-H) ppm. 13C NMR (125 MHz, [D6]DMSO, 75 °C): δ =
20.7, 20.9, 21.4, 21.5 [1,4-NHCO2CH(CH3)2], 54.9 (OCH3), 67.75, 67.80
[1,4-NHCO2CH(CH3)2], 79.7 (C-4), 94.3 (C-1), 108.8 (C-3′), 112.5
(C-3′′,5′′), 117.6 (C-8′), 122.8 (C-4′a), 124.5 (C-5′), 125.3 (C-6′), 127.3
(C-2′′,6′′), 127.6 (C-3), 133.1 (C-1′′), 134.2 (C-7′), 136.7 (C-2), 150.5,
154.5 [1,4-NHCO2CH(CH3)2], 155.2 (C-8′a), 158.5 (C-4′′), 163.7 (C-2′),
176.6 (C-4′) ppm. EI-MS: m/z (%) = 504 [M]+· (34), 418 (68), 377 (84),
358 (93), 332 (100). EI-HRMS: calcd. for C28H28N2O7 [M]+ 504.1897;
found 504.1898.
Computational Details: All quantum chemical calculations were
performed with the Gaussian 09 software package.[24] The opti-
mized geometries and respective electronic energies were com-
puted at the M06-2X/6-31+G(d,p) level of theory.[25] The structures
found were confirmed to correspond to true minima by frequency
calculations at the same level of theory, and no imaginary frequen-
cies were found. For some cases, the enthalpies at T = 298 K, H298K,
were calculated by considering the contributions of Eel, zero-point
energy (ZPE), and thermal enthalpy to T = 298.15 K; no scaling
factors were used (this is a reasonable approximation for relative
comparisons of molecular energetics). The energies of the HOMOs
and LUMOs for the optimized geometries of various dienes and
dienophiles were computed at the M06-2X/6-31+G(d,p) (within the
KS-MO formalism) and MP2/6-31+G(d,p) levels (Hartree–Fock MOs).
The HOMO/LUMO energy gap between the diene and dienophile
was calculated as ELUMO(dienophile) – EHOMO(diene); ELUMO and
EHOMO are the calculated energies of the respective molecular orbit-
als. All calculations were performed without symmetry restrictions.
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